Newsfile Corp
12 Nov 2025, 21:32 UTC · 44w ago
Verdict
Headline takes no side. We score INSP −1.00 across four claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Inspire Medical cut its 2025 earnings guidance by more than 80% due to the poor launch of its Inspire V device.
So whatA massive reduction in earnings guidance is a direct hit to valuation and investor confidence.
More negative than 99% of claims this week
The Inspire V launch suffered from weak market demand, excess inventory, and significant logistical delays in treatment center onboarding.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 96% of claims this week
A federal securities class action lawsuit has been filed against Inspire Medical alleging the company misled investors regarding the Inspire V rollout.
More negative than 87% of claims this week
Billing and reimbursement delays occurred because necessary Medicare software updates for the Inspire V did not take effect until July 1.
More negative than 73% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a securities class action lawsuit following a massive earnings guidance cut and a 32% stock price drop due to product launch failures.
More negative than 80% of ticker scores this week
The company is mentioned as being subject to a securities class action lawsuit deadline.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
20h ago
−15.7%
Price agrees with the score
$76.66 vs $90.91 close before publication (Nov 12) · not market-adjusted
INSP chart →
